Derivation of An In-Hospital Cardiac Arrest Prediction Model for Patients in Intensive Care Unit

In-Hospital Cardiac Arrest Clinical Trial

Official title:

Derivation of An In-Hospital Cardiac Arrest Prediction Model for Patients in Intensive Care Unit

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04670458
• Other study ID #: IHCA-EWS-QLH
• Status: Recruiting
• Start date: October 1, 2020
• Est. completion date: December 31, 2021

Study information

• Verified date: December 2020
• Source: Qilu Hospital of Shandong University
• Contact: Wentao Sang
• Phone: 15153187102
• Email: 752318151[@]qq.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Current studies have shown that hospitalized ICU patients have a high risk of IHCA, with an incidence of about 0.6-7.8%. Early prediction of the occurrence of IHCA in severe patients can provide early intervention, prevent the deterioration of the disease, and reduce the incidence of IHCA. Therefore, researchers wanted to verify the efficacy of MEWS, NEWS, and CART scores in predicting IHCA in ICU inpatients, and to establish an early-warning scoring model that could effectively predict the risk of IHCA occurrence in ICU inpatients during hospitalization.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2000
• Est. completion date: December 31, 2021
• Est. primary completion date: September 30, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 14 Years and older

Eligibility

CA group

Inclusion Criteria:

• Occurrence of IHCA

• Hospital stay =48h.

Exclusion Criteria:

• <14 years

• Do Not Resuscitat

• Patients hospitalized due to out-of-hospital cardiac arrest

• Cardiac arrest occurs during the operation

• The patients with implanted cardiac pacemaker suffered cardiac arrest due to instrument malfunction.

CONTROL group

Inclusion Criteria:

• Without IHCA

• Hospital stay =48h

Exclusion Criteria:

• <14 years

• Leave hospital without medical advice

Related Conditions & MeSH terms

• Heart Arrest
• In-Hospital Cardiac Arrest

Intervention

Other:
• no intervention
no intervention

Locations

Country	Name	City	State
China	Qilu Hospital of Shandong University	Jinan	Shandong

Sponsors (1)

Lead Sponsor	Collaborator
Qilu Hospital of Shandong University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	In-Hospital Cardiac Arrest	Cardiac arrest occurs during hospitalization	Day 2